TMHC Balance Sheet, Income & Cash Flow

Income Statement TMHC
Line item	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	LTM
Revenue	18.59	15.15	18.54	15.66	18.56	19.99	22.21	18.40	19.90	20.95	21.28	14.22	78.05
Cost of Revenue	14.05	11.48	14.09	11.79	14.11	14.97	16.68	13.88	15.21	16.18	16.59	11.24	60.54
Gross Profit	4.54	3.66	4.45	3.87	4.45	5.02	5.53	4.53	4.69	4.76	4.69	2.98	17.52
Selling, General & Administrative	0.64	0.62	0.69	0.62	0.77	0.77	0.78	0.66	0.65	0.65	0.75	0.60	2.72
Total Operating Expenses	1.66	1.52	1.73	1.57	1.83	1.88	1.93	1.71	1.79	1.81	1.97	1.53	7.25
Operating Income	2.88	2.15	2.72	2.30	2.62	3.14	3.60	2.81	2.89	2.96	2.72	1.45	10.26
Interest Expense	0.05	0.05	0.73	–	0.04	0.03	0.06	0.08	0.14	0.13	0.12	0.11	0.51
Pre-Tax Income	2.85	2.06	2.07	2.29	2.49	3.14	2.90	2.70	2.58	2.72	2.31	1.34	9.17
Income Tax Expense	0.73	0.52	0.48	0.53	0.63	0.77	0.60	0.63	0.66	0.68	0.51	0.31	2.22
Net Income	2.12	1.54	1.58	1.75	1.86	2.37	2.29	2.07	1.92	2.01	1.76	1.03	6.89
EBITDA	2.92	2.15	2.16	2.39	2.64	3.26	3.04	2.87	2.82	2.87	2.45	1.56	9.93

Data as of: July 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Income Statement